Cunninghamella bertholletiae infection

Also Known As:

C bertholletiae infection; C bertholletiae infections; C. bertholletiae infection; C. bertholletiae infections; Cunninghamella bertholletiae infections; Cunninghamella infection; Cunninghamella infections

Networked: 11 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Infections: 526564
- Bacterial Infections and Mycoses: 1
  - Mycoses: 11300
    - Zygomycosis: 370
      - Mucormycosis: 1758
        Cunninghamella bertholletiae infection: 11

Related Diseases

1.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
2.	Zygomycosis (Phycomycosis)
3.	Pulmonary Embolism
4.	Mucormycosis
5.	Infections

Experts

1.	Hiramoto, Rika: 1 article (01/2020)
2.	Hosoi, Hajime: 1 article (01/2020)
3.	Iehara, Tomoko: 1 article (01/2020)
4.	Kamei, Katsuhiko: 1 article (01/2020)
5.	Kuwahara, Yasumichi: 1 article (01/2020)
6.	Miyachi, Mitsuru: 1 article (01/2020)
7.	Nitta, Yoshihiro: 1 article (01/2020)
8.	Tsuchiya, Kunihiko: 1 article (01/2020)
9.	Yarita, Kyoko: 1 article (01/2020)
10.	Yoshida, Hideki: 1 article (01/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Cunninghamella bertholletiae infection:

1.	Amphotericin B (Amphotericin)FDA LinkGeneric 07/01/2001 - "Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature." 07/01/2001 - "bertholletiae was 4 microg/ml. Amphotericin B lung concentrations averaged 9.5 microg/ml (range 3.7-13.8 microg/ml), with a corresponding serum trough concentration of 0.9 microg/ml. To our knowledge, this is the first reported case of amphotericin B concentrations measured at the site of infection in a patient with a pulmonary Cunninghamella infection, together with a corresponding MIC of the organism. " 03/01/2010 - "Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature."
2.	Fungal DNAIBA 01/01/2020 - "Detection of circulating fungal DNA by polymerase chain reaction in a fatal case of Cunninghamella bertholletiae infection."
3.	Deferoxamine (Desferal)FDA LinkGeneric 11/01/1988 - "Cunninghamella bertholletiae infection associated with deferoxamine therapy."
4.	posaconazole FDA Link 03/01/2010 - "Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature."

Therapies and Procedures

1.	Therapeutics 09/01/1990 - "Unlike other agents of zygomycoses, Cunninghamella bertholletiae infection remains difficult to treat successfully even after early diagnosis and appropriate therapy." 11/01/1988 - "Cunninghamella bertholletiae infection associated with deferoxamine therapy."
2.	Induction Chemotherapy 12/01/2016 - "Here we report a girl with high-risk acute lymphoblastic leukemia who developed disseminated Cunninghamella bertholletiae infection during induction chemotherapy. " 12/01/2016 - "Disseminated Cunninghamella bertholletiae Infection During Induction Chemotherapy in a Girl with High-Risk Acute Lymphoblastic Leukemia."
3.	Liver Transplantation 09/02/2022 - "Fatal disseminated mucormycosis due to Cunninghamella bertholletiae infection after ABO-incompatible living donor liver transplantation: a case report."
4.	Kidney Transplantation 10/01/2002 - "Endocarditis and hemorrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation."
5.	Heart Transplantation (Grafting, Heart) 02/01/2018 - "We report a fatal case of disseminated Cunninghamella infection early after heart transplantation. "